Assembly Biosciences (ASMB) Cash & Current Investments (2016 - 2025)
Historic Cash & Current Investments for Assembly Biosciences (ASMB) over the last 11 years, with Q3 2025 value amounting to $232.6 million.
- Assembly Biosciences' Cash & Current Investments rose 14491.54% to $232.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $232.6 million, marking a year-over-year increase of 14491.54%. This contributed to the annual value of $112.1 million for FY2024, which is 1394.89% down from last year.
- As of Q3 2025, Assembly Biosciences' Cash & Current Investments stood at $232.6 million, which was up 14491.54% from $75.0 million recorded in Q2 2025.
- Assembly Biosciences' Cash & Current Investments' 5-year high stood at $232.6 million during Q3 2025, with a 5-year trough of $46.2 million in Q3 2023.
- In the last 5 years, Assembly Biosciences' Cash & Current Investments had a median value of $112.1 million in 2024 and averaged $122.0 million.
- In the last 5 years, Assembly Biosciences' Cash & Current Investments tumbled by 5746.93% in 2023 and then soared by 14491.54% in 2025.
- Over the past 5 years, Assembly Biosciences' Cash & Current Investments (Quarter) stood at $146.6 million in 2021, then tumbled by 37.52% to $91.6 million in 2022, then skyrocketed by 42.18% to $130.2 million in 2023, then dropped by 13.95% to $112.1 million in 2024, then skyrocketed by 107.49% to $232.6 million in 2025.
- Its Cash & Current Investments stands at $232.6 million for Q3 2025, versus $75.0 million for Q2 2025 and $91.0 million for Q1 2025.